Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(34:0) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 76.1 | pmol/sample |
| - | PE(34:0) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 117 | pmol/sample |
| - | PE(34:0) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 128 | pmol/sample |
| - | PE(34:0) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 76.9 | pmol/sample |
| - | PE(34:0) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 76.2 | pmol/sample |
| - | PE(34:0) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 31.8 | pmol/sample |
| - | PE(34:0) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 32.7 | pmol/sample |
| - | PE(34:0) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 38.3 | pmol/sample |
| - | PE(34:0) | C | 0.0 | BCD100427B001 | 102 | pmol/sample |
| - | PE(34:0) | C | 0.5 | BCD100427B003 | 59.8 | pmol/sample |
| - | PE(34:0) | C | 1.0 | BCD100427B007 | 154 | pmol/sample |
| - | PE(34:0) | C | 2.0 | BCD100427B011 | 61.2 | pmol/sample |
| - | PE(34:0) | C | 4.0 | BCD100427B015 | 89 | pmol/sample |
| - | PE(34:0) | C | 8.0 | BCD100427B019 | 54.4 | pmol/sample |
| - | PE(34:0) | C | 12.0 | BCD100427B023 | 28.6 | pmol/sample |
| - | PE(34:0) | C | 24.0 | BCD100427B027 | 52.4 | pmol/sample |
| - | PE(34:0) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 68.9 | pmol/sample |
| - | PE(34:0) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 77.3 | pmol/sample |
| - | PE(34:0) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 75.4 | pmol/sample |
| - | PE(34:0) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 61.3 | pmol/sample |
| - | PE(34:0) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 33.2 | pmol/sample |
| - | PE(34:0) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 33.8 | pmol/sample |
| - | PE(34:0) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 52.9 | pmol/sample |
| - | PE(34:0) | 25OH-Chol | 0.5 | BCD100427B004 | 141 | pmol/sample |
| - | PE(34:0) | 25OH-Chol | 1.0 | BCD100427B008 | 59.9 | pmol/sample |
| - | PE(34:0) | 25OH-Chol | 2.0 | BCD100427B012 | 142 | pmol/sample |
| - | PE(34:0) | 25OH-Chol | 4.0 | BCD100427B016 | 76.4 | pmol/sample |
| - | PE(34:0) | 25OH-Chol | 8.0 | BCD100427B020 | 35.5 | pmol/sample |
| - | PE(34:0) | 25OH-Chol | 12.0 | BCD100427B024 | 29.6 | pmol/sample |
| - | PE(34:0) | 25OH-Chol | 24.0 | BCD100427B028 | 39.2 | pmol/sample |